Spots Global Cancer Trial Database for xeliri
Every month we try and update this database with for xeliri cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) | NCT00127036 | Adenocarcinoma Colon Cancer | XELOX XELIRI Bevacizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer | NCT03511170 | Colorectal Neop... Chemotherapy | XELIRI XELOX | 18 Years - 75 Years | Harbin Medical University | |
| A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status | NCT05669092 | Toripalimab Radiation | Toripalimab CRT SCRT XELIRI FOLFRINOX | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | NCT01736904 | Colorectal Canc... | wXELIRI regimen FOLFIRI regimen | 18 Years - 70 Years | Fudan University | |
| Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment | NCT00717990 | Metastatic Colo... | Capecitabine Bevacizumab Irinotecan | 18 Years - 72 Years | University Hospital of Crete | |
| PRECISE CURATE.AI Pilot Clinical Trial | NCT04522284 | Solid Tumor | CURATE.AI Capecitabine XELOX XELIRI Ibrutinib | 21 Years - 99 Years | National University Hospital, Singapore | |
| Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) | NCT00127036 | Adenocarcinoma Colon Cancer | XELOX XELIRI Bevacizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer | NCT03511170 | Colorectal Neop... Chemotherapy | XELIRI XELOX | 18 Years - 75 Years | Harbin Medical University | |
| A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status | NCT05669092 | Toripalimab Radiation | Toripalimab CRT SCRT XELIRI FOLFRINOX | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | NCT01736904 | Colorectal Canc... | wXELIRI regimen FOLFIRI regimen | 18 Years - 70 Years | Fudan University | |
| A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC | NCT01996306 | Colorectal Neop... Neoplasm Metast... Intestinal Neop... Gastrointestina... Digestive Syste... | Bevacizumab CPT-11 (Irinote... 5-FU Bolus 5-FU Infusion l-LV (dl-LV) bevacizumab CPT-11 (Irinote... Capecitabine | 20 Years - | Epidemiological and Clinical Research Information Network | |
| wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | NCT01736904 | Colorectal Canc... | wXELIRI regimen FOLFIRI regimen | 18 Years - 70 Years | Fudan University | |
| XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer | NCT03511170 | Colorectal Neop... Chemotherapy | XELIRI XELOX | 18 Years - 75 Years | Harbin Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
